Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do you complain when your favorite store has a big sale? No.
This is no different.
Buy low,sell high. This is where you BUY.
Exactly. They clearly have no intention of doing an offering. Great news for shareholders.
100% agreed. Much has transpired and the quarterlies will tell the story here.
That's GREAT news Penny! That offering was filed before Hans became CEO and now it's been abandoned. Thanks for sharing!
.0005's getting loaded big time!
LOL I'm still here
Roadmap announcement coming *after* the conference you dummies.
Except, I don't think it'll go that low...
Great plan guys! Let's load the boat @.0003
Much much faster, easier, and cheaper to RM than to IPO. The trade off is that you basically have to give away a small portion of your company to some lowly otc traders lol.
The next two quarterlies will tell the story and PR to follow imo
Paul co-founded Nobelpharma and knows what he's doing!
Tweet from @CLXHealth:
REMINDER: @BeckersHR Conference next week. CSO Joseph Gonzalez will be participating in Data & Disrupters 10/14/20 at 2pm Eastern Announcements regarding partners and roadmap to follow. #HealthyAmerica #TrustedTravel #Technology #COVID19 #coronavirus
https://twitter.com/CLXHealth/status/1313852913886822401?s=19
CLXHealth stated that there will be announcements after the conference.
What more proof do you need?
If you're in $CNNA or $MEDH then you need to read this thread:
https://threadreaderapp.com/convos/1315866474851033091
If you're in $CNNA or $MEDH then you need to read this thread:
https://threadreaderapp.com/convos/1315866474851033091
I'm still here ;)
100% agreed! Big news Wednesday afterhours/Thursday premarket!
New tweet from Jason Black:
"Per Inquiries about $MEDH filings: Will all make sense soon where @The1OnlyHans and $CNNA are concerned. Hans gets full control of MEDH in exchange for a deal that benefits both sides big. Small CNNA R/S will benefit when deal unfolds. Easy to do good business with good people."
Per Inquiries about $MEDH filings: Will all make sense soon where @The1OnlyHans and $CNNA are concerned. Hans gets full control of MEDH in exchange for a deal that benefits both sides big. Small CNNA R/S will benefit when deal unfolds. Easy to do good business with good people.
— CNNA (@CNNA_OTC) October 13, 2020
That deal was unwound imo
Announcements after the conference, so maybe 4 or 5 pm
But then Hans came along and everything changed...
Quarterly reports'll tell the rest of this story...
Looks like the plan is for Hans to have full control.
Jason Black is the majority shareholder of $MEDH
He's the guy that put this deal together, apparently.
He's also the CEO and majority shareholder of $CNNA
5million volume @.0005, small paint-down @.0004
BIG TWEET OUT!!! UPDATES WEDNESDAY!!!
Getting ready to explode...
I also loaded low and am holding for big gains!
Glad to see the riffraff clearing out here... Blue skies after...
Just waiting on the Definitive Agreement for this other drug:
https://twitter.com/i_am_dunwifit/status/1306729573426618380?s=19
Companies lease space all the time...
TA update 10/6/20 and NO DILUTION EVER
Brain cancer deal next and more to come!
$CTYX here's why this is so huge:
IMT504 has been granted orphan drug status & qualifies for FDA Tropical Disease Priority Review Voucher (PRV) Program.
In 2016–2018, the value of a voucher ranged from $125 million to $200 million.
http://www.globenewswire.com/news-release/2020/10/09/2106348/0/en/Connectyx-Technologies-Holdings-Group-Inc-Announces-Definitive-Agreement-with-Mid-Atlantic-BioTherapeutics-Inc-for-Treatment-of-Symptomatic-Rabies.html
$CTYX here's why this is so huge:
IMT504 has been granted orphan drug status & qualifies for FDA Tropical Disease Priority Review Voucher (PRV) Program.
In 2016–2018, the value of a voucher ranged from $125 million to $200 million.
http://www.globenewswire.com/news-release/2020/10/09/2106348/0/en/Connectyx-Technologies-Holdings-Group-Inc-Announces-Definitive-Agreement-with-Mid-Atlantic-BioTherapeutics-Inc-for-Treatment-of-Symptomatic-Rabies.html
You can always slap back in when the time comes... Good luck to you!
Announcement coming Wednesday 10/14/20
Massive ad campaign when this launches.